Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and nsc 350386

pyrazines has been researched along with nsc 350386 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's9 (90.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griswold, DP; Harrison, SD; Temple, CG; Waud, WR1
Dykes, DJ; Elliott, WL; Griswold, DP; Harrison, SD; Laster, WR; Leopold, WR; Temple, CG; Waud, WR1
Bowdon, BJ; Dansby, L; Hain, R; Temple, C; Waud, WR; Wheeler, GP1
Allam, N; Briand, C; Leynadier, D; Manfait, M; Millot, JM; Peyrot, V; Temple, C1
Barasoain, I; Briand, C; de Ines, C; Garcia, P; Leynadier, D; Peyrot, V; Rener, GA; Temple, C1
Andreu, JM; Briand, C; Leynadier, D; Peyrot, V; Rener, G; Sarrazin, M; Temple, C1
Andreu, JM; Briand, C; Leynadier, D; Peyrot, V; Rener, GA; Sarrazin, M; Temple, C1
Barbier, P; Briand, C; Peyrot, V; Rener, GA; Sarrazin, M1
Barbier, P; D'Hoore, A; Dumortier, C; Engelborghs, Y; Peyrot, V; Rener, GA1
Andreu, JM; Barbier, P; Leynadier, D; Peyrot, V1

Other Studies

10 other study(ies) available for pyrazines and nsc 350386

ArticleYear
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:3

    Topics: Animals; Antineoplastic Agents; Drug Resistance; Leukemia P388; Mice; Mice, Inbred BALB C; Pyrazines; Vincristine

1992
Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in mice.
    Cancer research, 1990, Jun-01, Volume: 50, Issue:11

    Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms; Pyrazines; Tumor Cells, Cultured

1990
Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
    Cancer research, 1987, Mar-15, Volume: 47, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colchicine; Mitosis; Pyrazines; Structure-Activity Relationship; Swine; Tubulin; Vincristine

1987
Molecular interaction of tubulin with 1-deaza-7,8-dihydropteridines: a comparative study of enantiomers NSC 613862 (S) and NSC 613863 (R) by Raman and Fourier transform infrared spectroscopy.
    International journal of biological macromolecules, 1995, Volume: 17, Issue:1

    Topics: Animals; Cattle; In Vitro Techniques; Macromolecular Substances; Molecular Structure; Protein Binding; Protein Conformation; Protein Structure, Secondary; Pyrazines; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Stereoisomerism; Tubulin

1995
Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.
    Cancer research, 1994, Jan-01, Volume: 54, Issue:1

    Topics: Animals; Antineoplastic Agents; Carbamates; Cell Cycle; Cell Line; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mice; Microtubule Proteins; Microtubules; Pyrazines; Pyridines; Tumor Cells, Cultured

1994
Tubulin binding properties of two chiral isomers with 1-deaza-7,8-dihydropteridine structure.
    Advances in experimental medicine and biology, 1993, Volume: 338

    Topics: GTP Phosphohydrolases; Kinetics; Microtubules; Protein Binding; Protein Conformation; Pyrazines; Spectrometry, Fluorescence; Stereoisomerism; Tubulin

1993
Tubulin binding of two 1-deaza-7,8-dihydropteridines with different biological properties: enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+).
    Biochemistry, 1993, Oct-12, Volume: 32, Issue:40

    Topics: Animals; Antineoplastic Agents; Brain; Cattle; Kinetics; Molecular Structure; Protein Binding; Pyrazines; Spectrometry, Fluorescence; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship; Tubulin

1993
Differential effects of ethyl 5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate analogs modified at position C2 on tubulin polymerization, binding, and conformational changes.
    Biochemistry, 1995, Dec-26, Volume: 34, Issue:51

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Colchicine; Electrochemistry; GTP Phosphohydrolases; In Vitro Techniques; Kinetics; Ligands; Microtubules; Polymers; Protein Binding; Protein Conformation; Pyrazines; Spectrometry, Fluorescence; Stereoisomerism; Thermodynamics; Tubulin; Tubulin Modulators

1995
Kinetics of association and dissociation of two enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(-) (CI 980), to tubulin.
    Biochemistry, 1996, Feb-13, Volume: 35, Issue:6

    Topics: Animals; Binding Sites; Binding, Competitive; Cattle; Colchicine; In Vitro Techniques; Kinetics; Molecular Structure; Protein Binding; Pyrazines; Stereoisomerism; Swine; Tubulin

1996
The active GTP- and ground GDP-liganded states of tubulin are distinguished by the binding of chiral isomers of ethyl 5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate.
    Biochemistry, 1998, Jan-13, Volume: 37, Issue:2

    Topics: Guanosine Diphosphate; Guanosine Triphosphate; Hydrolysis; Ligands; Magnesium; Models, Chemical; Protein Binding; Protein Conformation; Pyrazines; Stereoisomerism; Tubulin

1998